
Mapping the RAS Mutation Landscape in Pancreatic Cancer with K-Dense Web
A research-focused case study showing how K-Dense Web analyzed global RAS mutation prevalence, drug eligibility, statistics, and the clinical-trial landscape in PDAC.
Blog
Explore tutorials, product updates, and insights on AI-powered research automation from the K-Dense team.
Showing 6 posts tagged "Drug Development".

A research-focused case study showing how K-Dense Web analyzed global RAS mutation prevalence, drug eligibility, statistics, and the clinical-trial landscape in PDAC.

K-Dense Web autonomously queried 4 live databases, ran 7 Python analysis scripts, and produced a 44-page competitive intelligence report on CT-388, Roche's dual GLP-1/GIP agonist for obesity.

K-Dense Web autonomously integrated 6 databases, ranked 6 candidate biomarkers, and produced Phase III trial design recommendations for CD20xCD3 bispecific antibodies in B-cell lymphoma.

K-Dense Web autonomously queried 6 databases, modeled KRAS structure, mapped the tumor microenvironment, and produced a 36-slide iNeST optimization strategy for pancreatic cancer neoantigen vaccines.

Our analysis of the complete GBM clinical trial database reveals three critical insights that explain why massive trial investment has failed to yield new approvals, and where the field must go next.

K-Dense is an agentic AI co-scientist platform purpose-built to transform translational research from a sequential, labor-intensive process into an integrated, insight-driven engine for drug development.